Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Published byDwain Walton Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive."— Presentation transcript:

1 Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies J Infect Dis. 2005;191(9): doi: /429302 J Infect Dis | © 2005 by the Infectious Diseases Society of America

2 Table 2 Baseline characteristics of HIV-1–positive subjects who received hepatitis B vaccination
From: Response to Hepatitis B Vaccine in HIV-1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies J Infect Dis. 2005;191(9): doi: /429302 J Infect Dis | © 2005 by the Infectious Diseases Society of America

3 Table 1 Univariable analysis of risk variables for antibody to hepatitis B core antigen (anti-HBc) in HIV-1–positive subjects who tested negative for hepatitis B surface antigen (HBsAg) and antibody to HBsAg From: Response to Hepatitis B Vaccine in HIV-1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies J Infect Dis. 2005;191(9): doi: /429302 J Infect Dis | © 2005 by the Infectious Diseases Society of America

4 Figure 1 Lower proportion of hepatitis C virus (HCV)–positive subjects with high titers of antibody to hepatitis B surface antigen (anti-HBs) after 3 vaccinations with hepatitis B vaccine, compared with HCV-negative subjects. The anti-HBs titer was measured 4 weeks after the third hepatitis B vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies J Infect Dis. 2005;191(9): doi: /429302 J Infect Dis | © 2005 by the Infectious Diseases Society of America

Download ppt "Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive."

Similar presentations

HEPATITIS A VIRUS. 012345678910111213 Week Response Clinical illness ALT IgM IgG HAV in stool Infection Viremia EVENTS IN HEPATITIS A VIRUS INFECTION.

HEPATITIS A VIRUS Week Response Clinical illness ALT IgM IgG HAV in stool Infection Viremia EVENTS IN HEPATITIS A VIRUS INFECTION.
Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.

Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.
Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.
In The Name of God.

In The Name of God.
Hepatitis B immune globulin

Hepatitis B immune globulin
Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.
Table 1. Baseline Characteristics of the 36,636 Study Subjects

Table 1. Baseline Characteristics of the 36,636 Study Subjects
Figure 1. Disposition of study participants, by group. Data are no

Figure 1. Disposition of study participants, by group. Data are no
Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Table 4 Results of 3 pairwise comparisons of expanded virus groups, by use of least-squares means differences and the Tukey honestly significant difference.

Table 4 Results of 3 pairwise comparisons of expanded virus groups, by use of least-squares means differences and the Tukey honestly significant difference.
Table 1. Prevalence of hepatitis B surface antigen (HBsAg) in west African cohorts from different countries. From: Low Genetic Diversity despite Hyperendemicity.

Table 1. Prevalence of hepatitis B surface antigen (HBsAg) in west African cohorts from different countries. From: Low Genetic Diversity despite Hyperendemicity.
Table 1 Characteristics of patients at enrollment who received artesunate-amodiaquine (ASAQ) or artemether-lumefantrine (AL) for treatment of malaria.

Table 1 Characteristics of patients at enrollment who received artesunate-amodiaquine (ASAQ) or artemether-lumefantrine (AL) for treatment of malaria.
Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.
L.S. Chathuranga, F. Noordeen, A.M.S.B. Abeykoon 

L.S. Chathuranga, F. Noordeen, A.M.S.B. Abeykoon 
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.

Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.
Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.
Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.
From: Rotarix: A Rotavirus Vaccine for the World

From: Rotarix: A Rotavirus Vaccine for the World

Similar presentations

Ads by Google